Puma Biotechnology | Należności Handlowe





Należności Handlowe Zmiana Data
Agios Pharmaceuticals USD 5.03M 43K 2025-09
Alnylam Pharmaceuticals USD 964.77M 397.66M 2025-09
Amgen USD 9.57B 1.08B 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Esperion Therapeutics USD 60.36M 5.75M 2024-06
Exelixis USD 311.3M 17.42M 2025-09
Gilead Sciences USD 5.1B 314M 2025-09
Glaxosmithkline GBP 11.16B 3.46B 2025-09
Incyte USD 1.02B 128.52M 2025-12
MacroGenics USD 69.23M 56.7M 2025-09
Moderna USD 1.05B 589M 2025-09
Novartis USD 8.98B 192M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
Takeda JPY 757.92B 55.68B 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Vertex Pharmaceuticals USD 1.95B 52.9M 2025-09


Puma Biotechnology Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.